326 related articles for article (PubMed ID: 30131072)
21. MiR-424-5p participates in esophageal squamous cell carcinoma invasion and metastasis via SMAD7 pathway mediated EMT.
Wang F; Wang J; Yang X; Chen D; Wang L
Diagn Pathol; 2016 Sep; 11(1):88. PubMed ID: 27628042
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-1290 promotes esophageal squamous cell carcinoma cell proliferation and metastasis.
Li M; He XY; Zhang ZM; Li S; Ren LH; Cao RS; Feng YD; Ji YL; Zhao Y; Shi RH
World J Gastroenterol; 2015 Mar; 21(11):3245-55. PubMed ID: 25805931
[TBL] [Abstract][Full Text] [Related]
23. [Expression of mir-106b in esophageal squamous cell carcinoma].
Xiao CY; Guo ZJ; Cao L; Ding XW; Liu Q; Wang XC
Nan Fang Yi Ke Da Xue Xue Bao; 2016 Dec; 36(12):1667-1671. PubMed ID: 27998862
[TBL] [Abstract][Full Text] [Related]
24. MiR-455-3p acts as a prognostic marker and inhibits the proliferation and invasion of esophageal squamous cell carcinoma by targeting FAM83F.
Yang H; Wei YN; Zhou J; Hao TT; Liu XL
Eur Rev Med Pharmacol Sci; 2017 Jul; 21(14):3200-3206. PubMed ID: 28770965
[TBL] [Abstract][Full Text] [Related]
25. Downregulation of miR-138 predicts poor prognosis in patients with esophageal squamous cell carcinoma.
Zheng S; Zhang X; Wang X; Li J
Cancer Biomark; 2017 Jul; 20(1):49-54. PubMed ID: 28759955
[TBL] [Abstract][Full Text] [Related]
26. Genome-wide screening for genetic alterations in esophageal cancer by aCGH identifies 11q13 amplification oncogenes associated with nodal metastasis.
Ying J; Shan L; Li J; Zhong L; Xue L; Zhao H; Li L; Langford C; Guo L; Qiu T; Lu N; Tao Q
PLoS One; 2012; 7(6):e39797. PubMed ID: 22761904
[TBL] [Abstract][Full Text] [Related]
27. CD47 expression regulated by the miR-133a tumor suppressor is a novel prognostic marker in esophageal squamous cell carcinoma.
Suzuki S; Yokobori T; Tanaka N; Sakai M; Sano A; Inose T; Sohda M; Nakajima M; Miyazaki T; Kato H; Kuwano H
Oncol Rep; 2012 Aug; 28(2):465-72. PubMed ID: 22641236
[TBL] [Abstract][Full Text] [Related]
28. TBL1XR1 promotes lymphangiogenesis and lymphatic metastasis in esophageal squamous cell carcinoma.
Liu L; Lin C; Liang W; Wu S; Liu A; Wu J; Zhang X; Ren P; Li M; Song L
Gut; 2015 Jan; 64(1):26-36. PubMed ID: 24667177
[TBL] [Abstract][Full Text] [Related]
29. Low levels of tumour suppressor miR-655 in plasma contribute to lymphatic progression and poor outcomes in oesophageal squamous cell carcinoma.
Kiuchi J; Komatsu S; Imamura T; Nishibeppu K; Shoda K; Arita T; Kosuga T; Konishi H; Shiozaki A; Okamoto K; Fujiwara H; Ichikawa D; Otsuji E
Mol Cancer; 2019 Jan; 18(1):2. PubMed ID: 30609933
[TBL] [Abstract][Full Text] [Related]
30. Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma.
Gao Y; Yi J; Zhang K; Bai F; Feng B; Wang R; Chu X; Chen L; Song H
J Exp Clin Cancer Res; 2017 Nov; 36(1):161. PubMed ID: 29145896
[TBL] [Abstract][Full Text] [Related]
31. Methylation-mediated repression of potential tumor suppressor miR-203a and miR-203b contributes to esophageal squamous cell carcinoma development.
Liu Y; Dong Z; Liang J; Guo Y; Guo X; Shen S; Kuang G; Guo W
Tumour Biol; 2016 Apr; 37(4):5621-32. PubMed ID: 26577858
[TBL] [Abstract][Full Text] [Related]
32. Clinical significance of microRNA-34a in esophageal squamous cell carcinoma.
Lin X; Xu XY; Chen QS; Huang C
Genet Mol Res; 2015 Dec; 14(4):17684-91. PubMed ID: 26782413
[TBL] [Abstract][Full Text] [Related]
33. LINC00152 facilitates tumorigenesis in esophageal squamous cell carcinoma via miR-153-3p/FYN axis.
Liu D; Gao M; Wu K; Zhu D; Yang Y; Zhao S
Biomed Pharmacother; 2019 Apr; 112():108654. PubMed ID: 30784933
[TBL] [Abstract][Full Text] [Related]
34. Serum exosomal miR-182 upregulation predicts unfavorable prognosis of esophageal squamous cell carcinoma.
Qiu ML; Li X; Lin JB; Luo RG; Liu B; Feng Z
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5412-5418. PubMed ID: 32495876
[TBL] [Abstract][Full Text] [Related]
35. Aberrant methylation-mediated silencing of lncRNA CTC-276P9.1 is associated with malignant progression of esophageal squamous cell carcinoma.
Guo W; Liu S; Dong Z; Guo Y; Ding C; Shen S; Liang J; Shan B
Clin Exp Metastasis; 2018 Feb; 35(1-2):53-68. PubMed ID: 29524086
[TBL] [Abstract][Full Text] [Related]
36. Amplification of the telomerase RNA component gene as a new genetic marker for disease progression and prognosis in esophageal squamous cell carcinoma.
Wang JD; Ma J; Wang FY; Peng LB; Wang X; Shi SS; Ma HH; Lu ZF; Lu GM; Zhou XJ
Dis Esophagus; 2013; 26(7):737-45. PubMed ID: 23317107
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-377 suppresses initiation and progression of esophageal cancer by inhibiting CD133 and VEGF.
Li B; Xu WW; Han L; Chan KT; Tsao SW; Lee NPY; Law S; Xu LY; Li EM; Chan KW; Qin YR; Guan XY; He QY; Cheung ALM
Oncogene; 2017 Jul; 36(28):3986-4000. PubMed ID: 28288140
[TBL] [Abstract][Full Text] [Related]
38. MiR-498 in esophageal squamous cell carcinoma: clinicopathological impacts and functional interactions.
Islam F; Gopalan V; Law S; Tang JC; Chan KW; Lam AK
Hum Pathol; 2017 Apr; 62():141-151. PubMed ID: 28188753
[TBL] [Abstract][Full Text] [Related]
39. BRCA1-Associated Protein Increases Invasiveness of Esophageal Squamous Cell Carcinoma.
Zhao Y; Wei L; Shao M; Huang X; Chang J; Zheng J; Chu J; Cui Q; Peng L; Luo Y; Tan W; Tan W; Lin D; Wu C
Gastroenterology; 2017 Nov; 153(5):1304-1319.e5. PubMed ID: 28780075
[TBL] [Abstract][Full Text] [Related]
40. Genome-wide screening of DNA methylation associated with lymph node metastasis in esophageal squamous cell carcinoma.
Nagata H; Kozaki KI; Muramatsu T; Hiramoto H; Tanimoto K; Fujiwara N; Imoto S; Ichikawa D; Otsuji E; Miyano S; Kawano T; Inazawa J
Oncotarget; 2017 Jun; 8(23):37740-37750. PubMed ID: 28465481
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]